| ASSET | YEAR | % RETURN |
|---|---|---|
UnitedHealth (UNH) | 2000 | 131.18% |
Thermo Fisher Scientific (TMO) | 2000 | 98.33% |
Eli Lilly and (LLY) | 2000 | 45.17% |
Wells Fargo (WFC) | 2000 | 41.12% |
Abbott Laboratories (ABT) | 2000 | 39.95% |
NVIDIA (NVDA) | 2000 | 38.8% |
Merck (MRK) | 2000 | 38.79% |
Novo Nordisk A-S (NVO) | 2000 | 32.82% |
AstraZeneca PLC ADR (AZN) | 2000 | 32.56% |
Novartis AG ADR (NVS) | 2000 | 31.15% |
Berkshire Hathaway (BRK.B) | 2000 | 28.99% |
Berkshire Hathaway (BRK.A) | 2000 | 26.56% |
Morgan Stanley (MS) | 2000 | 16.65% |
Johnson & Johnson (JNJ) | 2000 | 12.82% |
Exxon Mobil (XOM) | 2000 | 9.36% |
Coca-Cola (KO) | 2000 | 6.44% |
Chevron (CVX) | 2000 | 1.42% |
American Express (AXP) | 2000 | 0.8% |
Walt Disney (DIS) | 2000 | -0.39% |
Bank of America (BAC) | 2000 | -4.61% |
GE Aerospace (GE) | 2000 | -4.95% |
Intuitive Surgical (ISRG) | 2000 | -5.55% |
JPMorgan Chase (JPM) | 2000 | -6.54% |
Oracle (ORCL) | 2000 | -6.72% |
LIN TV (LIN) | 2000 | -10.37% |
Mega-cap stocks are treated as having a market cap of $200B+.
